Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 29,012 shares at $66.45 ($1.9M) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Scheduled sale ($1.9M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.45 | 14,506 | $964K | 50.0% |
| 2 | $66.45 | 14,506 | $964K | 50.0% |
| Total | $66.45 avg | 29,012 | $1.9M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |